Tag: MRI

MRI (Magnetic resonance imaging): A type of imaging designed to detect breast cancer that uses magnets and radio waves rather than radiation (mammogram) or sound waves (ultrasound). MRIs are more capable of detecting breast cancer in women with dense breasts than mammograms.

News

11/04/10: MRIs find additional disease in 20% of lobular BC patients

Studies

Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging Cite
Miceli R, Gao Y, Qian K, Heller SL. Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging. American Journal of Roentgenology. American Roentgen Ray Society; 2023; 221:34-43 10.2214/ajr.22.28698
Invasive Lobular Carcinoma: A Review of Imaging Modalities with Special Focus on Pathology Concordance Cite
Pereslucha AM, Wenger DM, Morris MF, Aydi ZB. Invasive Lobular Carcinoma: A Review of Imaging Modalities with Special Focus on Pathology Concordance. Healthcare. MDPI AG; 2023; 11:746 10.3390/healthcare11050746
Supplemental Breast Cancer Screening in Women with Dense Breasts and Negative Mammography: A Systematic Review and Meta-Analysis Cite
Hussein H, Abbas E, Keshavarzi S, Fazelzad R, Bukhanov K, Kulkarni S, et al. Supplemental Breast Cancer Screening in Women with Dense Breasts and Negative Mammography: A Systematic Review and Meta-Analysis. Radiology. Radiological Society of North America (RSNA); 2023; 10.1148/radiol.221785
High risk breast cancer screening is a double edged sword: A qualitative study of patient perspectives on the Ontario High Risk Breast Cancer Screening Program Cite
Deng SX, Castelo M, Reel E, Naganathan G, Eisen A, Muradali D, et al. High risk breast cancer screening is a double edged sword: A qualitative study of patient perspectives on the Ontario High Risk Breast Cancer Screening Program. Clinical Breast Cancer. Elsevier BV; 2022; 10.1016/j.clbc.2022.08.004
Diagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral Mammography Cite
Costantini M, Montella RA, Fadda MP, Tondolo V, Franceschini G, Bove S, et al. Diagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral Mammography. Journal of Personalized Medicine. MDPI AG; 2022; 12:867 10.3390/jpm12060867
A review on the added value of whole-body MRI in metastatic lobular breast cancer Cite
Bhaludin BN, Tunariu N, Koh D, Messiou C, Okines AF, McGrath SE, et al. A review on the added value of whole-body MRI in metastatic lobular breast cancer. European Radiology. Springer Science and Business Media LLC; 2022; 10.1007/s00330-022-08714-6
Impact of Preoperative MRI in Invasive Ductal Carcinoma With Lobular Features on Core Biopsy Cite
Jafferbhoy SF, Goussous G, Chandarana M, Salehi-Bird S, Mohd-Isa Z, Gunning E, et al. Impact of Preoperative MRI in Invasive Ductal Carcinoma With Lobular Features on Core Biopsy. Clinical Breast Cancer. Elsevier BV; 2021; 21:e194-e198 10.1016/j.clbc.2020.08.007
Invasive Lobular Breast Cancer: Data to Support Surgical Decision Making Cite
Cocco D, ElSherif A, Wright MD, Dempster MS, Kruse ML, Li H, et al. Invasive Lobular Breast Cancer: Data to Support Surgical Decision Making. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 28:5723-5729 10.1245/s10434-021-10455-7
Factors Affecting Time to Surgery in Breast Cancer Patients Cite
Chagpar AB, Howard-McNatt M, Chiba A, Levine EA, Gass JS, Gallagher K, et al. Factors Affecting Time to Surgery in Breast Cancer Patients. The American Surgeon. SAGE Publications; 2021;:000313482110547 10.1177/00031348211054714
Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging? Cite
Schumacher K, Inciardi M, O’Neil M, Wagner JL, Shah I, Amin AL, et al. Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 185:567-572 10.1007/s10549-020-06047-w
Interval Cancers after Negative Supplemental Screening Breast MRI Results in Women with a Personal History of Breast Cancer Cite
Kim GR, Cho N, Kim S, Han W, Moon WK. Interval Cancers after Negative Supplemental Screening Breast MRI Results in Women with a Personal History of Breast Cancer. Radiology. Radiological Society of North America (RSNA); 2021;:203074 10.1148/radiol.2021203074
Preoperative Breast MRI in Women 35 Years of Age and Younger with Breast Cancer: Benefits in Surgical Outcomes by Using Propensity Score Analysis Cite
Park AR, Chae EY, Cha JH, Shin HJ, Choi WJ, Kim HH. Preoperative Breast MRI in Women 35 Years of Age and Younger with Breast Cancer: Benefits in Surgical Outcomes by Using Propensity Score Analysis. Radiology. Radiological Society of North America (RSNA); 2021;:204124 10.1148/radiol.2021204124
Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma Cite
Lee J, Jung JH, Kim WW, Park CS, Lee RK, Kim HJ, et al. Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma. BMC Cancer. Springer Science and Business Media LLC; 2020; 20 10.1186/s12885-020-07443-7
Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience Cite
Bennett I, Tourani S, Cockburn L, Reasbeck J, Grobbelaar N, Dann S, et al. Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience. ANZ Journal of Surgery. Wiley; 2020; 10.1111/ans.16320
Outcome of Screening MRI in Premenopausal Women as a Function of the Week of the Menstrual Cycle Cite
Lee CH, Bryce Y, Zheng J, Sung JS, Comstock CE, Moskowitz C, et al. Outcome of Screening MRI in Premenopausal Women as a Function of the Week of the Menstrual Cycle. American Journal of Roentgenology. American Roentgen Ray Society; 2020; 214:1175-1181 10.2214/ajr.18.19960
Breast cancer survival following MRI detection in a high‐risk screening program Cite
Hollingsworth AB, Pearce MR, Stough RG. Breast cancer survival following MRI detection in a high‐risk screening program. The Breast Journal. Wiley; 2020; 26:991-994 10.1111/tbj.13813
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening Cite
Comstock CE, Gatsonis C, Newstead GM, Snyder BS, Gareen IF, Bergin JT, et al. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening. JAMA. American Medical Association (AMA); 2020; 323:746 10.1001/jama.2020.0572
Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma Cite
Lamb LR, Lehman CD, Oseni TO, Bahl M. Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma. Academic Radiology. Elsevier BV; 2020; 27:1394-1399 10.1016/j.acra.2019.09.025
Long-term survival outcomes in invasive lobular carcinoma patients with and without preoperative MR imaging: a matched cohort study Cite
Ha SM, Chae EY, Cha JH, Kim HH, Shin HJ, Choi WJ. Long-term survival outcomes in invasive lobular carcinoma patients with and without preoperative MR imaging: a matched cohort study. European Radiology. Springer Science and Business Media LLC; 2019; 29:2526-2534 10.1007/s00330-018-5952-7
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers Cite
Guindalini RSC, Zheng Y, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, et al. Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clinical Cancer Research. American Association for Cancer Research (AACR); 2018; 25:1786-1794 10.1158/1078-0432.ccr-18-0200
"What if I keep my breasts?" Extended follow-up of unaffected BRCA mutation carriers diagnosed with breast cancer (BC) in the Toronto magnetic resonance imaging (MRI) screening study. Cite
Warner E, Zhu S, Hill K, Causer P, Jong RA, Yaffe M, et al. "What if I keep my breasts?" Extended follow-up of unaffected BRCA mutation carriers diagnosed with breast cancer (BC) in the Toronto magnetic resonance imaging (MRI) screening study.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:1523-1523 10.1200/jco.2018.36.15_suppl.1523
The frequency of missed breast cancers in women participating in a high-risk MRI screening program Cite
Vreemann S, Gubern-Merida A, Lardenoije S, Bult P, Karssemeijer N, Pinker K, et al. The frequency of missed breast cancers in women participating in a high-risk MRI screening program. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 169:323-331 10.1007/s10549-018-4688-z
Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR Cite
Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. Journal of the American College of Radiology. Elsevier BV; 2018; 15:408-414 10.1016/j.jacr.2017.11.034
Abstract P4-02-10: Breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study Cite
Whitaker K, Guindalini R, Abe H, Sheeth D, Huo D, Hong S, et al. Abstract P4-02-10: Breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study. Poster Session Abstracts. American Association for Cancer Research; 2018; 10.1158/1538-7445.sabcs17-p4-02-10
Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography Cite
van Zelst JCM, Mus RDM, Woldringh G, Rutten MJCM, Bult P, Vreemann S, et al. Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography. Radiology. Radiological Society of North America (RSNA); 2017; 285:376-388 10.1148/radiol.2017161218
The true impact of breast magnetic resonance imaging on the management of in situ disease: more is not better Cite
Lallemand M, Barron M, Bingham J, Mosier A, Hardin M, Sohn V. The true impact of breast magnetic resonance imaging on the management of in situ disease: more is not better. The American Journal of Surgery. Elsevier BV; 2017; 213:127-131 10.1016/j.amjsurg.2016.05.002
Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers Cite
Krammer J, Pinker-Domenig K, Robson ME, Gönen M, Bernard-Davila B, Morris EA, et al. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 163:565-571 10.1007/s10549-017-4198-4
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers Cite
Lobbes MB, Vriens IJ, van Bommel AC, Nieuwenhuijzen GA, Smidt ML, Boersma LJ, et al. Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 162:353-364 10.1007/s10549-017-4117-8
Does preoperative breast MRI significantly impact on initial surgical procedure and re-operation rates in patients with screen-detected invasive lobular carcinoma? Cite
Sinclair K, Sakellariou S, Dawson N, Litherland J. Does preoperative breast MRI significantly impact on initial surgical procedure and re-operation rates in patients with screen-detected invasive lobular carcinoma?. Clinical Radiology. Elsevier BV; 2016; 71:543-550 10.1016/j.crad.2016.03.011
Breast MRI in Invasive Lobular Carcinoma: A Useful Investigation in Surgical Planning? Cite
Parvaiz MA, Yang P, Razia E, Mascarenhas M, Deacon C, Matey P, et al. Breast MRI in Invasive Lobular Carcinoma: A Useful Investigation in Surgical Planning?. The Breast Journal. Wiley; 2016; 22:143-150 10.1111/tbj.12566
High Prevalence of MRI-Detected Contralateral and Ipsilateral Malignant Findings in Patients With Invasive Ductolobular Breast Cancer: Impact on Surgical Management Cite
El Sharouni M, Postma EL, Menezes GL, van den Bosch MA, Pijnappel RM, Witkamp AJ, et al. High Prevalence of MRI-Detected Contralateral and Ipsilateral Malignant Findings in Patients With Invasive Ductolobular Breast Cancer: Impact on Surgical Management. Clinical Breast Cancer. Elsevier BV; 2016; 16:269-275 10.1016/j.clbc.2015.10.002
Time-Related Changes in Yield and Harms of Screening Breast Magnetic Resonance Imaging Cite
Pederson HJ, O'Rourke C, Lyons J, Patrick RJ, Crowe JP, Grobmyer SR. Time-Related Changes in Yield and Harms of Screening Breast Magnetic Resonance Imaging. Clinical Breast Cancer. Elsevier BV; 2015; 15:348-352 10.1016/j.clbc.2015.01.006
Effect of the Menstrual Cycle on Background Parenchymal Enhancement Observed on Breast MRIs in Korean Women Cite
Park VY, Kim E, Moon HJ, Yoon JH, Kim MJ. Effect of the Menstrual Cycle on Background Parenchymal Enhancement Observed on Breast MRIs in Korean Women. Journal of the Korean Society of Radiology. The Korean Society of Radiology; 2015; 73:158 10.3348/jksr.2015.73.3.158
Screening Breast MRI in Patients Previously Treated for Breast Cancer Cite
Giess CS, Poole PS, Chikarmane SA, Sippo DA, Birdwell RL. Screening Breast MRI in Patients Previously Treated for Breast Cancer. Academic Radiology. Elsevier BV; 2015; 22:1331-1337 10.1016/j.acra.2015.05.009
Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients Cite
Bick U. Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients. Breast Care. S. Karger AG; 2015; 10:13-20 10.1159/000375390
Nonsurgical Management of High-Risk Lesions Diagnosed at Core Needle Biopsy: Can Malignancy Be Ruled Out Safely With Breast MRI? Cite
Linda A, Zuiani C, Furlan A, Lorenzon M, Londero V, Girometti R, et al. Nonsurgical Management of High-Risk Lesions Diagnosed at Core Needle Biopsy: Can Malignancy Be Ruled Out Safely With Breast MRI?. American Journal of Roentgenology. American Roentgen Ray Society; 2012; 198:272-280 10.2214/ajr.11.7040
Breast Cancers Not Detected at MRI: Review of False-Negative Lesions Cite
Shimauchi A, Jansen SA, Abe H, Jaskowiak N, Schmidt RA, Newstead GM. Breast Cancers Not Detected at MRI: Review of False-Negative Lesions. American Journal of Roentgenology. American Roentgen Ray Society; 2010; 194:1674-1679 10.2214/ajr.09.3568
Screening Breast MR Imaging in Women with a History of Chest Irradiation Cite
Sung JS, Lee CH, Morris EA, Oeffinger KC, Dershaw DD. Screening Breast MR Imaging in Women with a History of Chest Irradiation. Radiology. Radiological Society of North America (RSNA); 2011; 259:65-71 10.1148/radiol.10100991
Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI? Cite
Heil J, Buehler A, Golatta M, Rom J, Schipp A, Harcos A, et al. Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?. Annals of Oncology. Elsevier BV; 2012; 23:98-104 10.1093/annonc/mdr064
Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast Cite
Biglia N, Bounous V, Martincich L, Panuccio E, Liberale V, Ottino L, et al. Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:199-204 10.1016/j.ejso.2010.12.011
Effect of the introduction of preoperative MRI scans for lobular cancer in an individual breast unit Cite
Cain H, Sinclair J, Martin A, Fasih T, Browell D, Clark K, et al. Effect of the introduction of preoperative MRI scans for lobular cancer in an individual breast unit. Breast Cancer Research. Springer Science and Business Media LLC; 2010; 12 10.1186/bcr2680
Decrease in Breast Density in the Contralateral Normal Breast of Patients Receiving Neoadjuvant Chemotherapy: MR Imaging Evaluation Cite
Chen J, Nie K, Bahri S, Hsu C, Hsu F, Shih H, et al. Decrease in Breast Density in the Contralateral Normal Breast of Patients Receiving Neoadjuvant Chemotherapy: MR Imaging Evaluation. Radiology. Radiological Society of North America (RSNA); 2010; 255:44-52 10.1148/radiol.09091090
Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial Cite
Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, König R, et al. Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1450-1457 10.1200/jco.2009.23.0839
622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis Cite
Jansen-van der Weide M, Greuter M, Jansen L, Oosterwijk J, Pijnappel R, Oudkerk M, et al. 622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis. European Journal of Cancer Supplements. Elsevier BV; 2010; 8:239 10.1016/s1359-6349(10)70642-x